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ABSTRACT

COMPARISON OF EXTRACTION TECHNIQUES FOR
~-9-TETRAHYDROCANNABINOL

FROM URINE

by Ashlyn Christine Harmon
May 2010
With the increasing use of marijuana, efficient methods to extract and detect ~-9THC in urine samples and relate the concentrations found to time is a necessity so that
impairment can be determined.

~-9-THC

is conjugated to glucuronic acid in urine and

must be freed before the compound can be detected by chromatographic procedures. In
past research, either a strong alkaline solution or p-glucuronidase has been used to cleave
the bond between the

~-9- THC

and glucuronic acid before an alkaline extraction.

~-9-

THC has a pKa of 10.6 and therefore is always extracted at an alkaline pH. In this study,
both a strong solution ofNaOH and the enzyme were used to break the glucuronide bond
in urine samples and the result obtained from each compared. This research first looked
at the best treatment for the glucuronide bond and secondly, determined if the extraction
could be completed at an acidic pH and still yield expected results. Fifty urine samples
from known marijuana users were treated with NaOH and extracted at an alkaline pH; the
same 50 samples were also treated with p-glucuronidase and extracted at an acidic pH.
The results from this part of the experiment showed that not only did the NaOH not work
as well as the enzyme, it did not cleave the bond at all. In order for a determination to be
made about the pH ofthe extraction, the same 50 samples were all treated with

P-

glucuronidase and then made alkaline before extraction. For the two extractions using
glucuronidase, t

(.05) ( IOO) =

0.283 for the height and t

11

(.05) ( IOO) =

0.277 for the area. The

P-

two extractions were proved to not be significantly different. The concentrations of ~-9THC in each sample were determined for both extractions. The t ratio for the
concentrations was calculated and again determined to not be significantly different;
t (05) (tOO) =

0.241 which fell well below the acceptable value of significance.
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CHAPTER I
INTRODUCTION
Forensic toxicology is the application of toxicology for legal purposes (Levine,
2006). The analysis of drugs and other toxic substance along with the determination of
their concentrations in biological samples constitutes the basis for this discipline of
toxicology. There are three major sub-disciplines that comprise forensic toxicology:
post-mortem forensic toxicology, human performance toxicology, and forensic drug
testing. In all of these disciplines, toxicology is used in combination with other fields of
chemistry such as analytical and clinical chemistry as well as pharmacology to determine
if, first, a toxic substance is present and secondly, if it is in a concentration high enough
to have caused intoxication or death.
In forensic toxicology, the extraction of the toxic substances from the biological
sample is the primary step in the qualitation and/or quantitation of any toxin(s) present.
This step is especially important to the process of determining if a toxin is present and if
so, its concentration, because the method chosen for analysis must be appropriate for the
toxin(s) to be extracted.
Extraction methods for analysis of biological samples for drugs can be done in
one of the two primary ways. Drugs are extracted from a sample by using liquid-liquid
extractions or by using solid-phase extractions. Both of these techniques have positive,
as well as negative qualities associated with them. The use of one versus the other is a
choice that an analyst must make depending on what drug is to be extracted and other
issues concerning time and effectiveness.
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Liquid-liquid extractions have been in use since the 1850s and have many
problems associated with them (Levine, 2006). The basis for this extraction technique is
the use oftwo immiscible liquids, water and an organic solvent. Liquid-liquid
extractions can be either basic or acidic depending on the pKa of the drug to be extracted.
To determine the pKa of the drug, the Henderson-Hasselbach equation should be used
(Levine, 2006). Once the appropriate pH is determined for extraction, a buffer can now
be selected for the extraction process.
As with most analyses, the first step of extraction is selecting a certain volume of
the sample to extract. This is dependent on the initial volume given to an analyst and the
drug in question. An aliquot should be placed in a clean test tube and the selected buffer
added. The solution of buffer and sample must be vortexed to thoroughly mix the two. If
a quantitation of the drug is desired, an appropriate internal standard should now be
added to the tube and vortexed. The next step in this process is the adding of an
extraction solvent. The solvent to be used is dependent upon the polarity and the type of
drug to be extracted from the sample. The specific gravity of the solvent should also be
considered when choosing an extraction solvent because this property will determine the
orientation of the solvent to the aqueous layer after centrifugation. Once this solvent is
added to the solution, the tubes are placed on a rotator for a period of time so that the
extraction solvent will mix with the sample and extract the drug. When the extraction
time is finished, the tube is centrifuged to separate the organic and aqueous layers. The
organic layer should be removed and placed into a new, clean test tube. The organic
solvent is now dried down so that the drug can be concentrated by dissolving in a smaller
volume of solvent.
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When a biological sample is extracted, the drug is not the only component of the
sample extracted. Other interfering compounds found in biological fluids, will also be
extracted. These interferences can be minimized, but not completely removed by using a
back extraction technique. This technique is an alteration of the normal liquid-liquid
extraction and is more time consuming and tedious.
Liquid-liquid extractions are fairly easy to complete, but can be somewhat time
consuming especially if a back extraction is necessary; back extractions are primarily
used for basic drugs/toxins. The normal process of liquid-liquid extractions is not quick
to begin with, but if a back extraction is required, the process is doubled in time and
material. A back extraction is completed by beginning in the same way as a normal
liquid-liquid extraction. The back extraction proces~ starts when then organic solvent is
transferred to a new test tube. The organic solvent is not dried down, but when extracting
basic drugs an acid is added to the solvent to precipitate out the drug from the organic
solvent. Many ofthe interfering substances are left behind in the organic solvent. The
solvent is now discarded. A buffer is added to the aqueous phase to make it basic once
again. The process now continues like the normal liquid-liquid extraction with the
organic layer being removed from the test tube and dried down so that the drug residue
can be concentrated.
With a liquid-liquid extraction, the greatest loss of recovery happens during the
first partitioning of the aqueous and organic extraction solvent. Seventy percent or
greater recovery can be expected (Levine, 2006). This percentage of recovery is apt to be
lower with the process of a back extraction. This is due to the multiple extractions with
loss of drug during each step. While back extractions are one of the more useful
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techniques of liquid-liquid extractions, it does not solve all problems that occur with this
technique.
Solid phase extractions (SPE) were first used in 1965 as an alternative extraction
method. Since then, SPE has undergone many improvements. SPE was designed by
scientist because of the many drawbacks and problems associated with liquid-liquid
extractions (Levine, 2006). SPE uses a stationary phase (column made of silica) which
has an affinity for desired compounds in the liquid sample. It also uses the principle of
affinity to discriminate against interferences based on their physical and chemical
properties.
The process of SPE starts by conditioning the stationary phase made of various
chemical components based on the extraction to be conducted. The first step of this
process is wetting the column with water and then methanol. The sample can now be
added to the column. This sample can be either "pushed" through the column using
positive pressure, or "pulled" through using negative pressure. The sample will settle
through out the column. A critical step is how fast the sample flows through the column;
too fast results in loss of drug and too slow increases the amount of interferences.
Theoretically, the wanted compounds will adhere to the column and the unwanted
interferences can be washed out using an organic solvent. Once the interferences are
removed, the drugs can be eluted by using a buffered organic solvent.
Since SPE does not usually use whole blood, like liquid-liquid extractions, the
problem of interferences is greatly reduced, but is not completely removed. SPE is
difficult when using whole blood because of the occurrence of clots and other particulate
matter that will clog the column and prevent the flow of sample or solute through the
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column (Levine, 2006). If an SPE column becomes clogged, it is of no further use and
must be discarded. This issue with SPE is especially difficult when dealing with
postmortem blood samples, given the often limited amount of sample received.
Other issues faced with SPE include the time spent washing and conditioning the
columns. Extractions using SPE use different volumes of solvent and other materials
involved and therefore require more time and effort from an analyst than does other,
more simple extraction processes (Siek, 2006).
Extractions like the ones discussed here are preliminary steps in the actual
analysis of drugs from biological samples. These extractions only aim to purify and
isolate the drug from the sample so that it can be further tested by other instrumentation.
The gas chromatograph/mass spectrometer (GC/MS) is considered the gold standard for
the analyses of drugs from biological samples. GC/MS is the best means of confirming a
drug 's identity. The GC/MS does encounter problems when the sample has not been
purified enough by the extraction method and interferences are still present in the final
product. Interferences cause problems both with the chromatography ofthe instrument
and identification of analytes. If enough ofthese interferences build up in the column of
the instrument, the column becomes inefficient for separation of analytes and a portion
must be cut off. If nothing is done to correct this problem, the peaks produced by the
GC/MS will become distorted from their proper Gaussian shape. This altered shape of
the curves produced may result in an incorrect reading in the concentrations of the drug
in the sample. As one can see, better methods of drug extraction from biological samples
are desired.
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CHAPTER II
REVIEW OF LITERATURE

Marijuana
Cannabis sativa, or marijuana, has been used by man for more than 4000 years
for many different purposes. Throughout history, one of the varieties of the plant that has
little or none of the psychoactive compound has been used for food and its fiber used to
make various items. The fiber from the marijuana plant is referred to as hemp fiber and
was used to make clothing and rope for sails. This variety of the Cannabis sativa plant is
more cane-like which yields more of the hemp fiber than other varieties of the plant
which are grown for their psychoactive compound (Huestis, 2006). Today, the seeds
from the plant can be sterilized to remove their psychoactive properties and used in
animal feed (Carroll, 1993).
The cannabis plant is indigenous to in Central Asia and was used by people in
China and India for medicinal purposes. These medical purposes included using
marijuana to treat problems such as rheumatism, muscle spasms, epilepsy, convulsions,
asthma, and for the purpose of relieving pain (Huestis, 2006). The use of marijuana to
treat migraines, stimulate appetite, and help with sleep disorders has also been noted as
medical uses for the drug (Bums, 2003). Marijuana was even discovered to have been
used by the Egyptians to help ease the pain associated with child birth. The use of
marijuana in European counties for medical purposes began in 1842, but was eventually
stopped due to there being no way to determine the potency of the dose, thus treatments
were not always successful (Huestis, 2006).
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Marijuana is not native to North America, but was brought over by the early
settlers in the 1600's who used the plant for hemp. Cannabis was the first cash crop to be
grown in Massachusetts (Carroll, 1993). The government actually required farmers to
grow marijuana because ofthe use of its fiber. Marijuana was an important part of
agriculture in America and its production was only exceeded by cotton. The
psychoactive properties of the plant were known during this time, but the public did not
recreationally use the drug (Carroll, 1993). Marijuana remained to be a vital part of
agriculture in America until the invention of the cotton gin and the ability to import hemp
at a lower cost from other countries eventually caused its growth as a cash crop and
production to be greatly reduced (Drug ID Bible, 2006).
Marijuana started being used in Western medicine during 1839 and continued to
be used medically for the next 100 years. During this time period, pharmaceutical
companies produced 28 different preparations of marijuana. These 28 preparations were
used to treat many different medical problems ranging from insomnia to menstrual
cramps. In 1935, marijuana abuse led to the Marijuana Tax Act of 1937. This act did not
outlaw marijuana, but imposed heavy taxes on farmers who cultivated the plant. Shortly
thereafter, all 28 ofthe preparations were removed from the market. Due to the tax act,
marijuana growth and production virtually stopped and the United States was reliant upon
the import of hemp fiber from Japan. However, due to World War II, Japan cut off the
supply of hemp to the U. S. Americans were now allowed to, and encouraged to, grow
marijuana for the production of hemp until the war was over in 1945 (Drug ID Bible,
2006).
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In the years after WWII to current times, marijuana abuse has continued to be an
issue in the United States. The use of marijuana as a recreational drug became popular in
the 1960's like many other drugs of abuse. It continues to be the most used illegal drug
today (Burns, 2003). Recently, many countries including Canada and England have
began to allow farmers to grow marijuana for the production of hemp fiber so that it can
be used to make things like paper, rope, and textiles. This variety of marijuana is referred
to as industrial hemp and contains 0.05-1.0% of the psychoactive ingredient. In the
United States today, a few cancer, AIDS, and glaucoma patients have been given
government permission to legally smoke marijuana to help ease the pain associated with
their condition (Drug ID Bible, 2006). Some of these patients are even prescribed
Marinol which is a preparation of the main psychoactive component found in marijuana
(Burns, 2003 ). Debates about the legalization of marijuana for medicinal purposes still
continue today.
Metabolism
Marijuana contains 61 cannabinoids of which one, ~-9-Tetrahydrocannabinol
9-THC) (see Fig. 1) produces almost all of the psychoactive effects.

~-9-THC

(~-

is

responsible for the behavioral and physiologic effects caused by marijuana. This
compound is found in the cannabis plant' s leaves and flowering regions.

~-9-THC

is a

tricyclic, 21-carbon compound that contains a phenol group; its molecular formula is
C21H3o02.

~-9-THC

(Huestis, 2006).

must be heated in order for it to become biochemically active
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~

OH
,,,H

.."''

~

H

............___
0

Figure 1.

~

~-9-Tetrahydrocannabinol

These effects of ~-9-THC are described as feelings of euphoria, but also include
impaired memory, lack of concentration, and paranoia. Increased appetite and heart rate
are among some of the more common physiological effects ·experience by users . ~-9THC is difficult to classify because it affects different individuals in different manners. It
is cannot be placed in one of the main categories of drugs (stimulants, tranquilizers,
sedatives or hallucinogens) definitely due to its wide range of effects on different users
(Huestis, 2006).
Marijuana is a central nervous system depressant at high doses and acts upon a
user through cannabinoid receptors in the brain. Marijuana is usually ingested by
smoking due to the quick and efficient delivery of the drug from the lungs to the brain,
although it can be used via oral route.

~-9-THC

has a bioavailability ranging from 18-

50%, when smoked, and ranging from 6-18% when orally ingested. Absorption of the
drug when orally ingested, versus smoking, is slower which makes smoking the usual
method of choice because the user feels the effects almost immediately, although the
effects last longer when ingested orally (Huestis, 2006).

When the drug is ingested
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orally, much of it is broken down in the stomach which accounts for its low
bioavailability.
due to the

~-9-THC

~-9- THC

~-9-THC

is quickly metabolized when used orally so the effects felt are

and its active metabolite, 11-0H-THC.

is highly lipophilic; this accounts for its distribution in fat and its long

half-life in the body.

~-9 - THC

is readily metabolized in the body to two metabolites due

to its lipophilic nature, one being an active metabolite and the other inactive (Kemp,
1995). Users may actually be impaired while his or her ~-9-THC will be very low or
non-detectable due to the quick metabolism of ~-9-THC by the body. Once ~-9-THC
enters the body through smoking marijuana or through oral ingestion, it undergoes
hydroxylation of the methyl group attached to the eleventh carbon ofthe structure by on
of the P450 enzymes which causes the production of the active metabolite, 11-hydroxytetrahydrocannabinol (11-0H-THC). 11-0H-THC is then further oxidized to

11-Nor-~-

9-THC-carboxylic acid (THC-COOH), which is the major, but inactive, metabolite found
in urine and blood. THC-COOH is conjugated to glucuronide (see Fig. 2) in urine and is
the main end product in the metabolism and excretion of ~-9-THC. After a user is has
ceased smoking, THC-COOH levels in urine will gradually reach and eventually surpass
the level of ~-9-THC in urine. This process is slow because the THC-COOH is polar and
is not rapidly cleared from the blood due to protein binding (Huestis, 2006).
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Figure 2. Glucuronic Acid

Around 20% of 6-9-THC's metabolites are excreted in the urine. During the first
5 days after use, a large portion of the drug is excreted from the body as THC-COOH and
11-0H-THC, with the urine containing mostly the THC-COOH. THC-COOH is
conjugated to glucuronic acid to promote water solubi lity so that it can be more easily
excreted. These conjugated metabolites have been identified in urine and are thought to
be key indicators of time period since the user ingested marijuana (Kemp, 1995). During
analysis of urine for THC-COOH, this glucuronide bond must first be broken so that the
THC-COOH or other metabolites can be detected and quantitated.

Determining Elapsed Time from Concentrations of6-9-THC and Its Metabolites
With the increased use of marijuana, methods for determining if an individual is
under the influence of marijuana has also become a priority. Since it is known that 6-9THC is rapidly converted to its daughter metabolites, high levels of the parent drug
would indicate recent use. In theory, the higher the ratio of the concentration of 6-9THC to its metabolites, the more recent an individual used marijuana. Experiments have
been conducted that monitor the time since marijuana use and compare these times to the
ratio of 6-9-THC concentration to its metabolites' concentration in either urine or
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plasma. By doing so, investigators are able to predict when an individual last used
marijuana and, therefore, determine if an individual is under the influence of the drug.
One previous study (Huestis et al., Blood Cannabinoids I, 1992) that tests the
above theory was performed using 6 volunteer males who either regularly or occasionally
used marijuana. These individuals were all thoroughly examined to ensure that they were
in good health. Each volunteer was given a drug test for not only ~-9-THC, but for other
drugs of abuse before the beginning of the study to ensure the accuracy of the results
obtained.
The marijuana cigarettes were obtained from the National Institute on Drug
Abuse and contained 0.0%, 1.75%, or 3.55% ~-9-THC. The administered amount of~9-THC to an individual was random. A computer was used to monitor the smoking to
ensure that each of the individuals inhaled the smoke, held it in, and exhaled for the same
length of time for the purpose of consistency. Eight inhalations were taken by each
individual throughout the smoking process.
During the smoking process, 10 blood samples were taken from each participant
at 1 minute intervals. After smoking, samples were taken at increasingly spaced intervals
which gave 34 total samples over the time of7 day. All blood samples were centrifuged
to provide plasma which was stored frozen until analysis. Analysis ofthe samples was
completed using capillary gas chromatography in combination with negative chemical
ionization mass spectrometry.
The results from the experiment showed that ~-9-THC immediately entered the
blood stream after the first inhalation of marijuana. Concentration of ~-9- THC steadily
rose during the smoking process with a mean value of7.0 ng/mL for individuals who had
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smoked the cigarette containing 1.75% ~-9-THC, and 18.1 ng/mL for participants who
had smoked the marijuana cigarette containing 3.55% ~-9-THC. The mean peak
concentration of ~-9-THC was found to be 84.3 ng/mL and 162.2 ng/mL, respectively.
After 2 hours, the levels of ~-9-THC found in plasma had dropped to 5 ng/mL or below.
However, the presence of ~-9-THC did remain detectable for up to 12 hours by GC/MS,
where the limit of detection was 0.5 ng/mL.
Analysis ofthe plasma samples for the two metabolites of ~-9-THC was
conducted to obtain ratios of the concentration of the parent drug to the concentrations of
its metabolites at various time intervals. 11-0H-THC, the first metabolite to form during
metabolism of ~-9-THC, was only detected in the plasma of one of the subjects after the
initially, but was detected in the plasma of three of the

subj~cts

after the third inhalation.

During the first 45 minutes after the start of smoking, the concentration of 11-0H-THC
remained in the range of 6-10% of the concentration of the

~-9-THC.

Mean peak levels

of6.7 ng/mL and 7.5 ng/mL 11-0H-THC occurred 13.5 minutes after the start of
smoking. Even though the concentration of 11-0H-THC started to fall , the ratio of [110H-THC]/[ ~-9- THC] began to increase after this time period due to the more rapid fall
ofthe ~-9-THC concentration in the plasma samples.
The second metabolite, THC-COOH, which is formed from the initial metabolite
11-0H-THC, appeared later in the plasma samples, as expected, but gradually rose,
plateaued then dissipated slowly. THC-COOH was not detected in all 6 of the subject' s
plasma until 8 minutes after the first inhalation. The peak concentrations for THCCOOH were much higher than those for the 11-0H-THC; 24.5 ng/mL and 54 ng/mL
were the mean peak concentrations of THC-COOH for the low and high doses of ~-9-
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THC, respectively. THC-COOH was detectable for a mean time period of 84 hours for
the low dose of 6-9-THC and for 152 hours for the higher dose.
The results of this research performed by Huestis demonstrates that after an
approximate time of 13.5 minutes from the initial inhalation ofthe marijuana cigarette,
the 6-9-THC levels decrease while the concentration of THC-COOH increases and
plateaus before it begins to gradually drop. The 11-0H-THC concentrations are shown to
peak early and drop quickly as compared to the THC-COOH. This means that the use of
a 11-0H-THC: 6-9-THC ratio for determining the time since a user ingested the drug by
inhalation would only be applicable during the first 2.5 hours after ingestion. The use of
a THC-COOH/ 6-9-THC ratio to determine time since ingestion of marijuana by
smoking would be of more value due to the lingering nature ofTHC-COOH in the body.
A second study also conducted by Huestis et al. , (Blood Cannabinoids II, 1992)
used the data and information obtained in the study above (Huestis et al. , Blood
Cannabinoids II, 1992). The data from the samples taken during the process was used to
construct mathematical models for the purpose of prediction of time intervals since
marijuana use.
Two models were derived from this data. The first of the models, Model I, uses
the relationship between the concentration of 6-9-THC and the time elapsed after
smoking while the second model, Model II, uses the ratio of THC-COOH to 6-9-THC
and time. Both models were formed using linear regression analysis. Model I states:
Log (T)

=

m

* log [THC] + b

T represents the predicted time after marijuana use and [THC] is the concentration of 69-THC quantitated in units of ng/mL. m is slope of the line, and b represents the y-
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intercept. Model II was derived similarly, but used both the concentration ofthe ~-9THC and its metabolite, THC-COOH, to form a working equation. Model II is as
follows:
Log (T) = m * log [THCCOOH]/[THC] + b
Like Model I, Tis representative of predicted time since marijuana ingestion, m is slope
and b is they-intercept. The only difference between the two models is the use of the
ratio between THC-COOH concentration and the concentration of ~-9-THC, and not just
the concentration of ~-9-THC.
Data from prior controlled experiments were used to test the accuracy of the
models. This data was obtained from users who had ingested marijuana in many ways,
including inhalation and oral ingestion; only data with concentrations of2 ng/mL or
higher were used. The accuracy of both models was tested in two ways.
First, by using absolute time error where the actual time elapsed was subtracted
from the predicted time elapsed and the absolute value taken. The models were also
tested for accuracy by comparing actual time after marijuana use to a 95% confidence
interval.
For Model I, the absolute time error when evaluating data from 238 plasma
samples from individuals who do not use marijuana frequently was 0.45 hours and when
actual time was compared to the 95% confidence interval, 221 samples fell within the
limits. Model I's predictability was also assessed using samples from subjects who used
marijuana regularly. Using ten of these plasma samples, Model I showed to have an
absolute time error of 0.17 hours and all ten of the predicted times using Model I fell with
in the 95% confidence interval.
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The absolute time error and confidence interval for Model II was calculated using
233 plasma samples from individuals who only occasionally used marijuana. The
absolute time error for Model II was 0.51 hours and 209 of the samples fell within the
95% confidence interval. Model II was also tested using plasma samples from
individuals who used marijuana regularly. The absolute time error for Model II was
found to be 1.1 hours and only ten out of 14 samples used fell within the 95% confidence
interval.
Three other studies, including one where the subjects orally ingested marijuana,
were also conducted to test the validity of the two models. Only one of all the studies
conducted, in which plasma samples from ten infrequent marijuana users were analyzed,
failed to demonstrate the predictability of the two models for time of ingestion. In this
study, the absolute time error for Model I was 1.05 hours and for Model II was 1.31
hours. Also, out of 84 samples, Model I only had 33 samples fall within the 95%
confidence interval and Model II had only 30 actual exposure times fall within the
confidence interval. While inaccurate, the predicted times of smoking exposure for both
models were consistently low. The lack of accuracy of the models in this study was
determined to be due to the lack of consistency in the smoking procedure.
Studies such as the ones noted here provide important information that can be
especially useful for forensic toxicologist when interpreting information from case
samples. Being able to accurately predict the time since someone has smoked marijuana
is especially useful when deciding if the drug did, in fact, contribute to a car accident or
any other situation in question by legal authorities (Huestis et al., Blood Cannabinoids II,
1992).
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Similar, more recent research (Manno et al. , 200 1) was completed that also
studied the relationship between time after smoking marijuana and the concentration of
1),-9-THC and its two main metabolites 11-0H-THC and THC-COOH. Like the method

noted above for determining an approximate time after marijuana use, researchers here
used a time to concentration relationship, but included another metabolite of 1),-9-THC,
8~ , 11-dihydroxy-THC,

in their research.

8~ ,

11-dihydroxy-THC is known to be

eliminated in urine during the 24 hours following use of the drug and was thought to be a
possible indicator for recent marijuana use, but was not proven useful in this study.
Manno et al. (200 1) then focused primarily on the concentrations of 1),-9- THC and
11-0H-THC because both analytes are pharmacologically active. Using the inactive
metabolite, THC-COOH, can help establish a time since use, but because it is inactive, no
relationship between it and human performance can be made. By using the active parent
analyte, 1),-9-THC, and its active metabolite, 11-0H-THC, not only can time since
marijuana use be determined, but also an interpretation of impairment can be made.
THC-COOH was analyzed during this study; it just was not the primary analyte of
interest.
Eight individuals with a history of occasional marijuana use were selected as
subjects for this experiment and evaluated for both physical and mental health. This
group of eight consisted of four females and four males. Each person was given a drug
screen for illicit drugs and breath test for ethanol on test days prior to the start of the
experiment. Female volunteers were also given pregnancy test before each experiment.
Marijuana cigarettes were obtained from Research Triangle Institute and
contained 0.0 %, 1.77 %, or 3.58% 1),-9-THC. Doses to individuals were chosen at
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random. A computerized program was used to ensure uniformity during the smoking
process. Time spent inhaling, holding, and exhaling by the individuals was controlled.
Plasma samples from the subjects were collected prior to the start of smoking, 5.0
minutes after smoking, and every hour for 8 hours after the smoking process. The
samples were placed in glass culture tubes and stored frozen until analysis.
The preparation and extraction process used for these plasma samples was
completed by a method previously determined by Kemp, et al. (1995). Bacterial

~

glucuronidase from E. coli was used to hydrolyze the glucuronide bonds of the analytes.
The matrix was then extracted at an acid pH with a solution of hexane and ethyl acetate
(7: 1) and quantitated via GC/MS following derivatization.
~-9- THC

concentrations in the plasma samples were the highest within the first

5.0 minutes after smoking. The peak concentrations for

~-9- THC

were shown to be dose

dependent. Samples from subjects who had been given the 1.77% ~-9-THC marijuana
cigarette had a mean peak concentration of 13.4 ng/mL +/- 3.9 ng/mL. The mean peak
concentration for subjects who smoked the marijuana cigarettes with 3.58% ~-9-THC
was 33.6 ng/mL +/- 6.2 ng/mL. Within just the first hour, however, the mean
concentrations of ~-9-THC had fallen to 5.5 and 2.5 ng/mL for the high and low dose,
respectively.
The active metabolite, 11-0H-THC, plasma concentration peaked at 5.0 minutes
after smoking. The mean concentrations for the low and high dose of ~-9-THC were 2.6
ng/mL +/- 0.9 ng/mL and 8.3 ng/mL +/- 2.1 ng/mL, respectively. Concentrations for 110H-THC fell to approximately half their mean peak value 1 hour after smoking.
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Mathematical models previously derived by Huestis et al. (Blood Cannabinoids II,
1992) were tested for accuracy using the data obtained during this experiment. Model I
and Model II were tested by using the 95% confidence interval. When used with the data
from this experiment, Model I predictions fell within the confidence interval. The
predicted times, however, were consistently overestimated before the 2 hour mark and
underestimated after the 4 hours after marijuana use. Model I produced predicted times
that were acceptable for a 95% confidence interval and was validated accordingly.
Model II also produced estimated times since marijuana use that were acceptable
for a 95% confidence interval. When using Model II, 24 of25 times predicted fell within
the acceptable range. Elapsed times since marijuana use were consistently overestimated
throughout the entire time period analyzed which gives it a high bias and makes it
appealing for legal purposes.
Urine samples from the subjects were also analyzed during this study. il-9-THC
levels in urine did not peak until 2 hours after smoking. il-9-THC concentrations did not
fall below the limit of detection in urine until 5 hours after smoking for the 1. 77% il-9THC dose and 7 hours for the 3.58% il-9-THC dose. Using the 2 ng/mL threshold, il-9THC concentrations could be quantitated for up to 5 hours after smoking for the high
dose of il-9-THC. For any concentration greater than 2 ng/mL in a urine sample, it could
be determined that an individual had used marijuana within the past 5 hours which is
within the time period that human performance is impaired.
11-0H-THC concentrations peaked around 3 hours after smoking, gradually
dropped, but never fell below the limit of detection for the entirety of the experimental
process. At the peak concentration, the mean for the low dose was 48.7 ng/mL+/- 11.5
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ng/mL and the mean for the high dose was found to be 77.3 ng/mL+/- 29.7 ng/mL. 110H-THC concentrations declined more slowly than did the L\-9-THC concentrations in
the urine as well as in the plasma samples.
L\-9- THC and 11-0H-THC concentrations as markers for time since marijuana

use were determined to be useful. It was determined that urine concentrations of L\-9THC greater that 2 ng/mL were indicative of marijuana use within the past 5 hours which
means that the individual was impaired by the drug within this time frame. Mathematical
models for prediction of elapsed time since marijuana use previously derived by Huestis
et al. (Blood Cannabinoids II, 1992) were verified using the data from plasma samples
gathered during this experiment. It was also found during this study that 8P-dihydroxyTHC concentrations could not be used as an indicator for time since marijuana use, as
previously established.
The above noted research uses plasma or urine samples from individuals who
have ingested marijuana by smoking to determine relationships between concentrations
of L\-9-THC and its metabolites and the time that had elapsed since an individual last
used marijuana. One study, (Kelly & Jones, 1992) however, looked at the relationship
between concentrations and time after individuals were given intravenous injections of L\9-THC. This method also differed from the prior noted methods of time determination in
that the researchers included a comparison of conjugated and unconjugated THC-COOH.
Plasma samples were collected at various time points throughout the injection
process, stored frozen, then analyzed and quantitated for L\-9-THC and THC-COOH. In
one set of plasma samples, the glucuronide bond was hydrolyzed by using 10 N NaOH;
in the other set, no method for hydrolyzing the glucuronide bond was performed. By
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treating the samples in such a manner, the concentration of unconjugated THC-COOH
could be subtracted from the total concentration of THC-COOH and the concentration of
conjugated THC-COOH determined. Before extraction, the plasma samples were made
acidic using 0.05 M H3P04 and further adjusting the pH to 3-4 with glacial acetic acid.
The plasma samples were extracted using solid phase extraction, derivatized
trifluoroacetic anhydride, and analyzed via GC/MS. Urine samples collected from the
same individuals were extracted, derivatized, and analyzed identically to the plasma
samples.
The ratio of free THC-COOH to conjugated THC-COOH greater than 2 only
occurred between the elapsed time of 2 and 30 minutes. After the 30 minute mark, all of
the ratios had dropped below 2 until negligible. Using a ratio. of free THC-COOH to
conjugated THC-COOH would not be of use after the 30 minute mark.
Researchers then turned to a previous method for time indication of marijuana use
that used a ratio oftotal THC-COOH, both conjugated and free, and 8.-9-THC (Law et
al., 1984). In this previous work decided a ratio less than 20 for THC-COOH to 8.-9THC was indicative of recent marijuana use. The study conducted by Kelly and Jones
(1992), however, made an even more specific determination and stated that use within the
last 45 minutes would yield a ratio of less than 1.
In all of the research conducted concerning the relationship between time and
concentrations of 8.-9-THC and its metabolites, the conclusions are consistent in that
accurate time predictions can be accomplished and the best analytes to use for prediction
oftime use is 8.-9-THC and either 11-0H-THC or THC-COOH. Successful predictions
oftime have been accomplished by Huestis (1992) and Manno (2001) using
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mathematical models relating the concentrations of the parent drug and its metabolites.
Estimated time of marijuana use has also been accomplished by simply using the ratio of
parent drug to metabolite concentrations. Useful means which predict elapsed time since
marijuana ingestion occurred need to be fully developed and so that these methods can be
used to give a better indication of impairment of an individual involved in legal cases.
Removal of the Glucuronide Bond
Research in the past has also been conducted to determine more effective methods
of identifying and quantitating ~-9-THC and its metabolites in urine. With increasing
marijuana use throughout the nation, analytical techniques that detect ~-9- THC and its
metabolites need to be optimized (Kemp, 1995). Methods and procedures are needed that
focus on the effectiveness of identifying the drug and its m~tabolites, and the time it takes
to do so.
Since ~-9-THC is readily converted by the body to its major metabolites, analysis
of urine and plasma samples for these metabolites and

~-9- THC

is often performed.

Preparation of samples before extraction includes a step in which the glucuronide bond is
hydrolyzed so that the conjugated metabolites can be detected. Research has been
conducted on different ways of breaking this bond so that the maximum recovery of the
conjugated metabolites can be obtained.
Typically, either p-glucuronidase or alkaline conditions are used for the purpose
of cleaving the bond between the

~-9-THC

metabolites and the glucuronic acid.

P-

glucuronidase can be obtained from seven species including bacteria, mollusk, bovine
and limpet. The source from which the enzyme is obtained is dependent on what pH is
used during the hydrolysis process (Kemp et al. , 1995). p-glucuronidase, however, is
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usuaJiy obtained from either Escherichia coli (bacteria, optimal at pH 6.8) or Helix

pomatia (mollusk, optimal at pH 5.0).
Two studies (Kemp et al. 1995) conducted simultaneously focused on improving
the method for hydrolysis. The studies focused on which of three possible methods of
hydrolysis of the glucuronide bond would give the best recovery when extracting

~-9-

THC, 11-0H-THC, and THC-COOH from urine. Once the best reagent for hydrolysis
had been determined, the concentration of the enzyme and the incubation period was also
optimized to yield the best recovery of ~-9-THC and its metabolites in urine and plasma.
Eight occasional marijuana users, who were physically and mentally in good
health, were selected to be subjects in these studies. Four of the individuals were male
and four were females. Each subject was given a urine drug test prior to the start of each
session to ensure no illicit drugs were present. Breath alcohol test were administered to
each participant and female subjects were given pregnancy test.
Marijuana cigarettes containing 3.58% ~-9-THC were obtained from Research
Triangle Institute; each volunteer smoked one of these cigarettes. The pace at which the
subjects smoked was controlled by a computer. Inhalation, holding and exhalation were
all standardized. A total of eight inhalations from the marijuana cigarette were conducted
by each of the volunteers.
The collection of urine from the individuals began 5 minutes after the first
inhalation from the cigarette and was collected once an hour for 8 hours following the
cessation of the smoking process. Samples were stored in a frozen until analysis. Urine
collected from a male subject one hour after smoking was used for comparison of the
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three hydrolysis methods. Four, 1 mL aliquots were obtained from this stored urine for
analysis and placed in glass culture tubes.
Enzymatic hydrolysis of the glucuronide bond was completed using

P-

glucuronidase from E. coli and Helix pomatia. For the urine samples hydrolyzed using
enzymes, 30 ng/mL of deuterated internal standards for the ~-9-THC, 11-0H-THC and
THC-COOH were added to both ofthe 1 mL aliquots of urine. The urine samples were
brought to the correct pH for the enzyme (pH 6.8 or pH 5.0) and 1mL of 0.1 M phosphate
buffer was added to the p-glucuronidase from both sources so that optimal conditions for
enzyme function would be obtained. 5000 Fishman units ofthe bacterial p-glucuronidase
was added to the urine sample with a pH of 6.8 and 5000 Fishman units of the

P-

glucuronidase from Helix pomatia were added to the urine sainple with a pH of 5.0. The
tubes were capped and placed in a water bath at 37° for incubation overnight.
Alkaline hydrolysis of the glucuronide bond was completed using NaOH. A
sample of urine was again spiked with 30 ng/mL of deuterated internal standards of ~-9THC, 11 -0H-THC and THC-COOH. The urine was brought to a pH of 13.0 with NaOH
and placed in a 60° C water bath for 15 minutes. After incubation, the urine sample was
removed from the water bath and allowed to cool to room temperature.
The researchers performing this experiment also included a control in which no
hydrolysis procedure would be used for one urine sample. The sample was spiked with
the same concentrations of deuterated internal standards as the samples that underwent
hydrolysis. 1 mL phosphate buffer was added to the control urine sample so that all four
samples would have an equal volume of liquid.
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For the purpose of extraction of the analytes from all of the urine samples, a basic
extraction was performed first by increasing the pH of the samples to 13.0 and then using
a mixture ofhexane and ethyl acetate to extract the

~-9-THC

and 11-0H-THC. This

solvent portion of the matrix was removed and dried completely. The THC-COOH was
extracted from the samples by making the remaining sample acidic, then adding a
mixture of hexane and ethyl acetate to extract the THC-COOH. The solvent was again
removed and dried completely. Each sample was derivatized using N,o-Bis
(Trimethylsilyl) trifluoroacetamide (BSTFA) and analyzed via GC/MS.

After extraction and analysis, the 13-glucuronidase from E. coli was determined
to be the best option for hydrolysis with the enzyme from Helix pomatia a far second
best. For the control sample, concentrations of ~-9-THC and 11-0H-THC were very
low. This indicated that no unconjugated

~-9-THC

or 11-0H-THC was present in the

urine 1 hour after smoking. The concentration of THC-COOH, however, was found to be
1. 7 ng/mL. This shows that the initial step in the extraction process when the base is
added is enough to cleave the THC-COOH from the glucuronide bond, even without
incubation.
The urine sample treated with NaOH showed similar recovery concentrations to
that of the control. Neither the ~-9-THC nor 11-0H-THC concentrations increased by
using alkaline conditions as the form of hydrolysis of the glucuronide bond. Also, the
THC-COOH concentration was not significantly affected by the basic hydrolysis. The
data gathered from this experiment showed that using base as the mean of hydrolysis will
not yield the expected concentrations of ~-9-THC or 11-0H-THC, and the same THCCOOH concentration can be obtained by performing no hydrolysis at all.
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The use of p-glucuronidase for hydrolyzing the glucuronide bond of the analytes
of interest in urine proved to be the method of choice. p-glucuronidase from E. coli
yielded much higher concentrations of ~-9- THC and 11-0H-THC than any other
hydrolysis method including the p-glucuronidase from Helix pomatia. Even by doubling
the concentration of the P-glucuronidase from Helix pomatia to 10,000 units, the
recovery of the 11-0H-THC was still lower that using the original 5000 units of Pglucuronidase from E. coli. In the initial experiment, however, the highest concentration
of THC-COOH was quantitated using 5000 units of p-glucuronidase from Helix pomatia.
The use of the mollusk enzyme provided the highest yield of THC-COOH out of all the
reagents used for hydrolysis. Further experiments using both sources of P-glucuronidase
showed that the enzymes both produced high recoveries ofTHC-COOH. Overall, the
most efficient reagent for the hydrolysis of the glucuronide bond for ~-9-THC, 11-0HTHC, and THC-COOH proved to be the P-glucuronidase from E. coli.
Now that the investigators had determined the best reagent for the removal of the
glucuronide bond from

~-9-THC

and its two main metabolites, the determination of what

concentration of the bacterial P-glucuronidase should be used and the selection of an
ideal incubation time for the reagent in biological specimen was completed.
Researchers used urine from a subject who had smoked one, 3.58% ~-9-THC
marijuana cigarette 1 hour prior to urine collection. The urine was divided into 1 mL
samples and placed in glass culture tubes and stored in a freezer.
Kemp et al. (1995) proceeded to optimize the concentration of the Pglucuronidase used for hydrolysis by using three concentrations of the enzyme to
hydrolyze 1 mL urine samples. Concentrations of 1500, 5000, and 10,000 Fishman units
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of the

~-glucuronidase

were compared. Incubation times for the enzyme in urine samples

were also studied so that an optimal time could be selected. 0.25, 1.5, 4.0, and 16.0 hours
were all tested to determine which of the times would allow for the best recovery of the
analytes.
For the purposes of this experiment, 11 -0H-THC was the only analyte quantitated
and its concentrations used for the determination of the optimal concentration of the
enzyme and for the incubation period. Using the same extraction method as the first
experiment described, it was determined that the concentration of 5000 Fishman units
and an incubation time of 16 hours (overnight) was the best conditions for the process
when considering not only effectiveness, but price and convenience. While 10,000
Fishman units did yield a slightly higher recovery, 5000 Fishman units and not 10,000
units was selected as the best concentration due to cost efficiency. 16 hours was selected
because it yielded the best recovery of 11-0H-THC and was found to be the most
convenient time period for the individuals performing the analysis.
~-glucuronidase

from the E. coli bacteria shows to be the best option for the

removal of the glucuronide conjugate. The enzyme produced the best recovery of 11-9THC and its two major metabolites when compared to two other popular methods of
hydrolysis. The method of use of bacterial

~-glucuronidase

for the purpose of hydrolysis

was also optimized and produced high recovery of the 11-9-THC and the conjugated
metabolites.
The proposed research will focus on making the quantitation of 11-9-THC in urine
more time and cost efficient. Adding a strong solution ofNaOH to the urine samples will
not only break the glucuronide bond, but will also make the urine basic so that no pH
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adjustment will be necessary for extraction. The samples will then be incubated for a
longer period oftime than normally used so that maximum recovery of conjugated and
free

~-9- THC

can be extracted from the samples.

A comparison of the proposed method for extraction and a more traditional
method of extraction will be completed. Typically, p-glucuronidase from E. coli is used
to hydrolyze the glucuronide bond and the extraction for

~-9- THC

is completed under

acidic conditions. By comparing the recovery, linearity, and limit of detection of the two
methods, a determination of the usefulness of the proposed research can be made.
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CHAPTER III
MATERIALS AND METHODS
Procedure
Once 50 urine samples from donors were collected, each sample was divided into
three, 4 mL aliquots and treated with NaOH for an alkaline extraction at pH 11.0. The
samples were also treated with

~-glucuronidase

and then extracted at an acidic pH of 6.5

and at an alkaline pH of 11.0.
Preparation ofSodium Hydroxide Solution

A 10 M solution of sodium hydroxide (NaOH) was added to each test tube
containing urine to break the glucuronide bonds. 500 mL of the 10M NaOH solution
was made by the following steps:
1.

40 g ofNaOH (Fisher Scientific, Houston, TX) was accurately weighed out and
placed into a 100 mL Erlenmeyer flask.

2.

Type I water (Millipore, Billierica, MA) was added to the flask until a volume of
100 mL was reached.

3.

A stirring bar was added to the flask and the flask placed on the magnetic hot
plate until all of the NaOH had dissolved.

Buffer Preparation

The buffer solution used was a 1.0 M, pH 6.5 sodium phosphate buffer. This
buffer was made by using monobasic sodium phosphate salt (NaH2 P04 ) and dibasic
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sodium phosphate salt (Na2HP04 ) dissolved in Type III water. To make this buffer, the
following steps were completed:
1.

69.00 grams of monobasic sodium phosphate salt (NaH2P04 ) (Fisher Scientific,
Houston, TX) was accurately weighed out, placed in a 500 mL Erlenmeyer flask,
and brought to a volume of 500 mL with Type III water (Millipore, Billierica,
MA) to give a 1.0 M buffer solution with a pH of 4.5. The pH will be verified
with an Accumet 25XL pH meter (Fisher Scientific, Houston, TX).

2.

134.04 grams of dibasic sodium phosphate salt (Na2HP04 ) was accurately
weighed out, placed in a 500 mL Erlenmeyer flask, and brought to a volume of
500 mL with Type III water to give a 1.0 M buffer solution with a pH of9.5. The
pH will be verified with an Accumet 25XL pH meter ·(Fisher Scientific, Houston,
TX).

3.

A one liter beaker was then obtained and 500 mL of dibasic buffer added;
measured increments of the monobasic buffer were added to the dibasic buffer
with a 10 mL volumetric pipette. A stirring bar was then added and the beaker
placed on to a magnetic hot plate to ensure continuous mixing of the two buffers.
The pH was measured throughout the addition of the monobasic buffer until the
desired pH of 6.5 is achieved. The flask of buffer solution was then covered with
Parafilm and stored at 4 ° C for later use.

Making of~- 9-THC Standards
In order to create a calibration curve so that

~-9-THC

in the urine samples can be

quantitated, direct standards will be made. This was completed through the following
process:
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1.

A standard with a concentration of lmg/mL (Cerilliant, Round Rock, TX) was
obtained and diluted with 9 mL of methanol for a final concentration of 0.1
mg/mL.

2.

1 mL of this solution was placed into a new, clean test tube and add 9 mL of
methanol added for a solution equal to 10

3.

~-tg/mL.

1 mL of this solution was placed in another new, clean test tube and add 9 mL of
methanol. This will gave a concentration of 1 ~-tg/mL.

4.

A 100 ~-tg/mL standard of 6-9-THC-D3 was purchased from Cerilliant (Round
Rock, TX) and diluted to 10
~-tg/mL

~-tg/mL.

~-tg/mL

with 9 mL of methanol. 1 mL of the 10

solution was diluted with 9 mL of methanol for a final concentration of 1
40 J.!L of this 1 J.Lg/mL 6-9-THC-D3 was used as the internal standard

for all standards and samples so that each was equivalent to 10 ng/mL.
5.

Direct standards were created by adding 10, 20, and 80 J.!L of the 1 J.Lg/mL
standard to separate test tubes. 40 J.!L of 1 J.Lg/mL 6-9-THC-03 was also be
added to each tube. These standards corresponded to 6-9-THC concentrations of
2.5, 5.0, and 20 ng/mL.

6.

The standards were dried completely in a Rapidvap (Thermo-Fisher, Houston,
TX) then reconstituted using 50J,!L of Bis(Trimethylsilyl)-trifluoroacetamide
(BSTF A). The samples were capped and incubated at 60°C for 30 minutes to
derivatize the 6 -9-THC and the 6-9-THC-D3 internal standard.
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Alkaline Extraction oftl-9-THC in the Urine Samples Using NaOH
Once the tl-9-THC standards were prepared, the alkaline extraction of the urine
samples was started. This was accomplished through the following steps:
1.

100 J..tL of a 10 M NaOH solution was added to each of the 50 test tubes and was
incubated at 37°C in a water bath for 1.5 hours.

2.

After incubation, the tubes were allowed to cool to room temperature and 9 mL
of a Hexane:Ethyl Acetate solution (4:1) was added and capped.

3.

The tubes were placed on a platform rotator for 1.5 hours and mixed at a slow
speed to prevent emulsion.

4.

The tubes were centrifuged at 3000 RPM for 25 minutes following the
extraction.

5.

The Hexane:Ethyl Acetate solutions were transferred to clean 16x125 mm tubes
and evaporated at 60°C in a Rapidvap (Thermo-Fisher, Houston, TX).

6.

Once dry, the tubes were allowed to cool and then 50 J..tL ofBis(Trimethylsilyl)trifluoroacetamide (BSTF A) was added to each tube and the tubes capped.

7.

All the tubes were capped and then heated at 60°C for a minimum of 30 minutes
to derivatize the tl-9-THC and internal standard.

8.

The tubes were allowed to cool to ambient temperature and then transferred to
auto sampler vials containing 100 J..tL inserts.

9.

All vials were capped and placed on the GC/MS for injection.

10.

2 J..tL of each sample was analyzed using a Gas Chromatograph/ Mass
Spectrometer (Clarus 600 EI+, Perkin Elmer, Shelton, CT).
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Acid Extraction of!l-9-THC in Urine Samples using fJ-glucuronidase

The acid extraction process will be accomplished by completing the following
steps:

1.

100 J.!L of ~- glucuronidase from E. coli (Thermo Fisher, Houston, TX) was
added to all test tubes.

2.

Each sample was buffered with 1 mL of 1.0 M sodium phosphate buffer (pH
6.5) and incubated in a 37 °C water bath for 60 minutes.

3.

9 mL of a hexane:ethyl acetate solution (4:1) was added to each sample and the
tubes capped.

4.

The tubes were placed on a platform rotator for 1 hour and mixed at a slow
speed to prevent emulsion.

5.

The tubes were all centrifuge at 3000 RPM for 25 minutes following the
extraction.

6.

The hexane:ethyl acetate solutions were transferred to clean 16x 125 mm tubes
and evaporated at 60°C in a Rapidvap (Thermo-Fisher, Houston, TX).

7.

Once dry, the tubes were allowed to cool and then 50 J.!L of Bis(Trimethylsilyl)trifluoroacetamide (BSTFA) was added to each tube and the tube capped.

8.

All of the tubes were vortexed and then heated at 60°C for a minimum of30
minutes to derivatize the /l-9-THC and internal standard.

9.

The tubes were allowed to cool to ambient temperature and then the solution
transferred to autosampler vials containing 100 J.!L inserts.

10.

The vials were capped and placed on the GC/MS for injection.
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2 f.!L samples were analyzed using a Gas Chromatograph/ Mass Spectrometer
(Clarus 600 Et, Perkin Elmer, Shelton, CT).

Alkaline Extraction of1'1-9-THC in Urine Samples using {3-glucuronidase

The alkaline extraction process using P-glucuronidase will be accomplished by
completing the following steps:
1.

100 f.!L of P-glucuronidase from E. coli (Thermo Fisher, Houston, TX) was
added to all test tubes.

2.

Each sample was buffered with 1 mL of 1.0 M sodium phosphate buffer (pH
6.5) and incubated in a 37 °C water bath for 60 minutes.

3.

100 f.!L of 1.0 M NaOH was added to each of the test tubes in order to make the
urine samples alkaline.

4.

9 mL of a Hexane:Ethyl Acetate solution (4:1) was then added to each sample
and the tubes capped.

5.

The test tubes were placed on a platform rotator for 1 hour and mix at a slow
speed to prevent emulsion.

6.

The tubes were then centrifuge at 3000 RPM for 25 minutes following the
extraction.

7.

The hexane:ethyl acetate solutions were transferred to clean 16x125 mm tubes
and evaporated at 60°C in a Rapidvap (Thermo-Fisher, Houston, TX).

8.

Once dry, the tubes were allowed to cool and then 50 f.!L ofBis(Trimethylsilyl)trifluoroacetamide (BSTFA) was added to each tube and the tube capped.

9.

All tubes were vortexed and then heated at 60°C for a minimum of30 minutes
to derivatize the 1'1-9-THC and internal standard.
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10.

The tubes were allowed to cool to ambient temperature and then transferred to
autosampler vials containing 100 )lL inserts.

11.

All vials were capped and place on the GC/MS for injection.

12.

2 )lL of all samples was analyzed using a Gas Chromatograph/ Mass
Spectrometer (Clarus 600 Et, Perkin Elmer, Shelton, CT).

GC/MS method parameters for both extraction processes were as follows:
Duration: 14.0 minutes
Solvent Delay Start 1: 0.0 minutes
Solvent Delay End 1: 12.6 minutes
Solvent Delay Start 2: 14.2 minutes
Solvent Delay End 2: 16.0 minutes
Number of Functions: 1
Function 1: SIR of 5 masses
Time: 12.70 to 14.10 minutes
Ion Mode: Er+
Inter Channel Delay: 0.01 seconds
Channel

Mass(Da)
371,386, 387

Dwell(s)
0.05
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2

389,390

0.05

Instrument Control Method

Instrument Name: Clarus MS I
Instrument Type: PE AutoSystem GC with built-in Autosampler
Channel Parameters

Solvent Delay Time: 0.00 minutes
Run Time: 16.00 minutes
Autosampler Method

Syringe Capacity: 5.0 ~L
Inj ection Speed: Normal
Viscosity Delay: 0
Pre-Injection Solvent Washes: 2
Post-Injection Solvent Washes: 10
Injection Volume: 2

~L

Sample Pumps: 3
Wash/Waste Vial Set: 1
Pre-injection Sample Washes: 0
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Carriers Parameters
Carrier Control: PFlow-H2
Column Length: 30.00 meters
Diameter: 25 0 J.lm
Vacuum Compensation: On
Split Flow: 25.0 mL/minute
Flow Rate: 0.50 mL/minute
Initial Hold: 999.0 minutes

Valve Configurations and Settings
Valve 1: Split On

Heated Zones
Injector A: CAP
Setpoint: 250 °C
Transferline: 270 oc
Mass Spectrometer Sources: 170 °C
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Oven Program
Cryogenics: Off
Initial Temperature: 80 oc
Maximum Temperature: 300 °C
Initial Hold: 2.00 minutes
Equilibration Time: 0.2 minutes
Ramp: 15 °C/ minute to 280 oc, hold for 0.67 minutes
Timed Events
Split 1 set to 0 at -0.30 minutes
Split 1 set to 50 at 3.00 minutes
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CHAPTER IV
DATA AND RESULTS
Urine samples from anonymous donors who use marijuana were collected and
used for the purpose of this research. Collection cups in brown paper bags with informed
consent forms and urine classification forms were issued to a third party individual who
distributed the bags to anonymous participants who were known marijuana users. The

•

filled cups and classification forms were returned by the third party individual to the
laboratory and stored locked until the research process began. All collection methods and
procedures were approved by the Internal Review Board (IRB) of the University of
Southern Mississippi. The IRB form, informed consent form, and urine classification
form can be found in Appendixes A, B, and C.
A total offifty (50) samples were collected from three classifications of marijuana
users. Each participant recorded the number of times they use marijuana per week, the
time period it had been since they last smoked marijuana, and the method by which they
ingested marijuana. Of the samples collected, 39 participants recorded that they were
heavy smokers, 8 said that they were light smokers and 3 considered themselves medium
smokers. Thirty three people smoked marijuana cigarettes, 16 participants used a pipe,
and 1 donor smoked marijuana by blunt. The time frame since participants last smoked
ranged from 20 minutes to 4 hours. The urine sample classification form also contained a
blank for the participants to indicate if they were ingesting marijuana at the time they
donated the urine sample. None of the users indicated that they were using marijuana
while they were collecting urine so this category was omitted from the sample description
table (see Table 1).
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Table 1

Sample Descriptions

Sample No.

Marijuana Use

Time Frame

Method of Ingestion

0001
0002
0003
0004
0005
0006
0007
0008
0009
0010
00 11
0012
0013
0014
00 15
00 16
00 17
0018
00 19
0020
002 1
0022
0023
0024
0025

Heavy
Heavy
Heavy
Heavy
Heavy
Heavy
Heavy
Light
Medium
Heavy
Heavy
Light
Heavy
Heavy
Light
Heavy
Heavy
Heavy
Heavy
Heavy
Heavy
Light
Heavy
Heavy
Heavy

30 minutes
1.5 hours
1 hour
2.5 hours
3.5 hours
1.5 hours
3.5 hours
5 hours
3 hours
45 minutes
2 hours
20 minutes
1 hour
2.5 hours
2 hours
45 minutes
45 minutes
30 minutes
1 hour
1.5 hours
30 minutes
1 hour
2 hours
2.5 hours
1 hour

Pipe
Pipe
Blunt
Pipe
Pipe
Pipe
Pipe
Pipe
Pipe
Pipe
Pipe
Pipe
Pipe
Pipe
Pipe
Pipe
Pipe
Marijuana Cigarette
Marijuana Cigarette
Marijuana Cigarette
Marijuana Cigarette
Marijuana Cigarette
Marijuana Cigarette
Marijuana Cigarette
Marijuana Cigarette
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Table 1, cont.
Sample Descriptions (cont.)

Sample No.

Marijuana Use

Time Frame

Method of Ingestion

0026
0027
0028
0029
0030
0031
0032
0033
0034
0035
0036
0037
0038
0039
0040
0041
0042
0043
0044
0045
0046
0047
0048
0049
0050

Heavy
Light
Heavy
Heavy
Medium
Heavy
Heavy
Heavy
Heavy
Heavy
Heavy
Light
Heavy
Light
Heavy
Heavy
Heavy
Heavy
Medium
Heavy
Heavy
Heavy
Light
Heavy

30 minutes
45 minutes
1 hour
2.5 hours
2 hours
3 hours
1.5 hours
30 minutes
45 minutes
1 hour
2.5 hours
1.5 hours
30 minutes
2.5 hours
4 hours
3.5 hours
2 hours
45 minutes
30 minutes
30 minutes
2 hours
1.5 hours
3 hours
2.5 hours
1 hour

Marijuana Cigarette
Marijuana Cigarette
Marijuana Cigarette
Marijuana Cigarette
Marijuana Cigarette
Marijuana Cigarette
Marijuana Cigarette
Marijuana Cigarette
Marijuana Cigarette
Marijuana Cigarette
Marijuana Cigarette
Marijuana Cigarette
Marijuana Cigarette
Marijuana Cigarette
Marijuana Cigarette
Marijuana Cigarette
Marijuana Cigarette
Marijuana Cigarette
Marijuana Cigarette
Marijuana Cigarette
Marijuana Cigarette
Marijuana Cigarette
Marijuana Cigarette
Marijuana Cigarette
Marijuana Cigarette

Heav~

Table 1: Description of the samples obtained from participants who use marijuana.
Heavy denotes those participants who use marijuana everyday, medium is
representative of participants who use marijuana 1-3 times a week, and light is
indicative of those participants who use marijuana 1 time a month or recreationally.
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The first extraction performed on the urine samples was the acidic extraction at
6.5 using

~-glucuronidase.

Four mL of each urine sample was placed into a test tube and

spiked with 6-9-THC-03 internal standard to give a concentration of 10 ng/mL. One mL
of 1.0 M sodium phosphate buffer was added to each of the 50 samples to buffer the urine
to create an optimum pH environment for

~-glucuroidase.

The samples were then treated

with 100 flL of the ~-glucuronidase from E. coli. before being placed in a 3rC water
bath for 1.5 hours. The urine samples were removed from the water bath and extracted
with Hexane:Ethyl Acetate (4:1) for 1.5 hours on a platform rotator. The extraction
solvent was removed and dried completely before being reconstituted and derivatized for
30 minutes at 65° C with Bis(trimethylsilyl)trifluoro acetamide (BSTFA) + 1%
trimethylsilyl (TMS). The samples were analyzed via GC/MS using selective ion
monitoring and quantitated using the 386 and 389 ion fragments.
The 389 internal standard ion fragment's area and height were measured by peak
integration. The mean, standard deviation, and estimated standard error for the 389 area
and height were calculated so that they could be later used to determine the efficiency of
the acidic extraction versus the initial basic extraction (See Table 2).
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Table 2
/)-glucuronidase 389 Ion Area and Height

~-Giu.

389

389

Sample No.

ion area

ion height

0001
0002
0003
0004
0005
0006
0007
0008
0009
0010
0011
0012
0013
0014
0015
0016
0017
0018
0019
0020
0021
0022
0023
0024
0025

14393
17095
10294
19149
18904
9412
15942
24563
18585
6795
12441
15765
15756
17673
7798
11959
10596
18938
13394
12930
7405
12050
12622
10832
16032

794973
901509
518276
1002041
1043677
504615
790738
1293703
1011591
371533
665313
803598
791133
897652
444485
627988
529645
958914
694693
703919
382989
690510
674762
288179
832375

44
Table 2, cont.
/3-glucuronidase 389 Ion Area and Height (cont.)

Sample No.

389
ion area

389
ion height

0026
0027
0028
0029
0030
0031
0032
0033
0034
0035
0036
0037
0038
0039
0040
0041
0042
0043
0044
0045
0046
0047
0048
0049
0050

8176
13974
10196
8618
7339
8227
4858
3426
4072
6227
9778
7057
7981
7694
9187
5977
10161
8794
3998
6636
9098
6164
10337
5381
6576

414499
756934
561887
473625
393727
435176
267655
192830
227105
345139
498037
404100
433329
424618
515476
329192
569095
488852
217594
343875
514134
348817
539342
254160
352187

P-Giu.

Mean

10620.47059

Standard Dev.

4929.657

Est. Std. Error

497.945

Mean
Standard
Dev.
Est. Std.
Error

559227.1569
259735.274
26235.886

Table 2: Calculations for ~-glucuronidase area and height of the 389 ion
fragment from .::1-9-THC-D3 internal standard used to establish any significant
difference between the extractions at pH 6.5 and pH 11.
Mean = :EX/N
Sandard Dev. = ~[(:EX2/N)-Mean2 ]
Est. Std. Error= SD/~(N~ -1 + N2-l)
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An alkaline extraction of another 4 mL of the same 50 urine samples was

performed by using a strong solution ofNaOH to break the glucuronide bond. As with
the acidic extraction, 4 mL of each of the 50 samples was placed into clean test tubes and
~-9- THC-D3

internal standard added to give a final concentration of 10 ng/mL. Ten

molar NaOH (100!-!L) was added to each of the 50 samples before they were placed into a
3rc water bath for 1.5 hours. The test tubes were removed from the water bath and 9
mL ofHexane:Ethyl Acetate (4:1) was added to each sample and extracted for 1.5 hours
by mixing on a platform rotator. When finished, the samples were centrifuged and the
extraction solvent removed, dried completely, reconstituted with BSTFA and incubated
for 30 minutes at 65° C to derivatize the

~-9-THC

and the internal standard.

The samples were then analyzed via GC/MS and the 389 ion fragment's area and
height measured. The basic extraction using NaOH did not yield any ~-9- THC so the
compound's 386 ion fragment could not be used for comparison of efficiency. The 389
ion fragment was used to determine the effectiveness of the two different pH extractions.
The mean, standard deviation, and estimated standard error of the 389 ion's area and
height were each calculated for statistical comparison with the acidic extraction (See
Table 3). (The 386 ion fragment from

~-9-THC

was not used to compare the two

techniques to determine efficiency due to the absence of the ion fragment when the
NaOH was used to cleave the glucuronide bond. However, the 386 ion's area and height
from the acidic 13-glucuronidase extraction were both measured and recorded for
statistical comparison to an altered basic extraction described later on.)
The mean values for both area and height of the 389 ion for the basic NaOH
extraction were higher than those from the acidic 13-glucuronidase extraction. The
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standard deviation for the area and height of the ion fragment for the basic extraction was
also less than that of the acidic extraction; therefore, the estimated standard error was less
for the basic extraction using NaOH. Overall, the results for the un-conjugated 389
internal standard ion fragment were more consistent with the basic extraction than the
acidic extraction.
A statistical comparison of the acidic and basic extraction techniques was
completed using the previous calculated 389 ion values from Tables 2 and 3. To
determine if the two extractions were statistically different, a two-tail t test was
performed at the .05 level of significance. The estimated standard error of difference for
both the area and the height for the two extractions was calculated. Then, using the
means from each, at ratio was determined. This ratio was then compared to a t value
table for a degree of freedom of 120. The t ratio calculated for the two extractions
exceeded the value from the table which meant the two extractions were significantly
different (See Table 4).
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Table 3

NaOH 389 Ion Area and Height

NaOH
Sample No.

389
ion area

389
ion height

0001
0002
0003
0004
0005
0006
0007
0008
0009
0010
00 11
0012
0013
0014
0015
0016
0017
0018
0019
0020
0021
0022
0023
0024
0025

902 1
5421
12824
12632
12802
9677
1463 1
13201
12573
9497
9162
8754
13241
13405
13356
13499
11536
14058
4930
13634
9953
11 869
10771
11656
14043

500695
309502
707619
675017
693488
53540 1
771324
720978
682823
535645
499413
486746
735737
722440
720024
707704
629958
744 113
267893
743073
545529
651397
577819
643128
788542
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Table 3, cont.
NaOH 389 Jon Area and Height (cont.)

NaOH
Sample No.

389
ion area

389
ion height

0026
0027
0028
0029
0030
0031
0032
0033
0034
0035
0036
0037
0038
0039
0040
0041
0042
0043
0044
0045
0046
0047
0048
0049
0050

17927
13006
13450
13107
11617
12719
12933
12807
6601
13238
10438
11572
12196
10652
11156
10244
5489
10072
10901
12347
9267
9562
8946
11105
10987

993447
736469
765675
711763
651384
701910
720757
694880
381825
736987
582140
633464
639679
597070
599751
597782
296208
563709
603179
680824
519659
534332
502247
594259
600786

Mean 11154.39216
Standard Dev.
2893.109
292.233
Est. Std. Error

Mean 612482.0196
Standard Dev. 158058.679
Est. Std. Error 15965.523

Table 3: Calculations for NaOH area and height of the 389 ion fragment from
~-9-THC-03 internal standard used to establish any significant difference between
the extractions at pH 6.5 and pH 11.
Mean = LX!N
Sandard Dev. = .V[(LX2/N)-Mean2]
Est. Std. Error = SD/.V(N1 -1 + N2-1)
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Table 4

Statistical Comparison off>-glucuronidase and NaOH Ion

fl-glu 389 Height
NaOH 389 Height

Mean

Standard
Error

Est Stand Error of Difference

570404
624724

25219.829
480.391

25224.404

2.153

1(.05)(100) =

fl-glu 389 Area
NaOH 389 Area

10825.1
2475.56

480.391
25.261

1(.05)(100)

481.055

=

17.357

Table 4: Statistical comparison of the two methods for breaking the glucuronide
bond. Using the 389 ion fragment's average height and area, for the acidic and basic
extractions, the two methods proved to be signigficantly different. The t value for
the .05 level of significance for a degree of freedom of 120 is 1.98. Both of these
calculated values fall outside this level and are therefore significantly different.
2
2
Est. Std. Error of Difference = --f(SE 1 + SE2 )
tratio

= (Mean1-Mean2)/SED
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In order to do a comparison of extraction efficiencies for ~-9-THC for an acidic
and a basic extraction, another set of 50 samples had to be extracted using ~
glucuronidase to cleave the glucuronide bond and then using 10 M NaOH to bring the
urine back to a basic pH before extraction.
Like in the other two procedures, 4 mL of each of the samples was placed into a
test tube and spiked with

~-9-THC-D3

samples was first treated with

internal standard at 10 ng/mL. This set of

~-glucuronidase

and placed in a water bath at 37°C for 1.5

hours. When the samples were removed from the water bath, 100 J!L of 10M NaOH was
added to each test tube and vortexed before extraction with Hexane: Ethyl Acetate (4:1)
for 1.5 hours. The extraction solvent was removed, dried down, reconstituted using
BSTFA, and then incubated for 30 minutes at 65° to ensure derivatization of both the ~9-THC and the

~-9-THC-D3.

These 50 samples were analyzed via GC/MS and statistics

calculated for the 386 and 389 ion fragments' areas and heights (See Tables 5 and 6).
Since data concerning the 386 ion fragment from an acidic and basic extraction
had now been obtained, these values could be statistically compared to determine if there
was a significant difference in the two

~-glucuronidase

extractions for ~-9- THC.
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Table 5
f)-glucuronidase Acidic 386 and 389 Jon Areas and Heights

P-Giu.
Acidic
Sample No.

386

386

389

389

ion area

ion height

ion area

ion height

0001
0002
0003
0004
0005
0006
0007
0008
0009
0010
0011
0012
0013
0014
0015
0016
0017
0018
0019
0020
0021
0022
0023
0024
0025

3814
2142
15964
4346
730
582
795
0
386
3432
814
0
14729
930
0
19334
8870
2025
2026
1587
2184
691
549
1442
24835

207493
123954
773392
107852
44443
32772
44558
0
21657
186884
43477
0
804213
37502
0
1041438
502056
55210
109181
84204
99470
43706
35820
77540
479521

14393
17095
10294
19149
18904
9412
15942
24563
18585
6795
12441
15765
15756
17673
7798
11959
10596
18938
13394
12930
7405
12050
12622
10832
16032

794973
901509
518276
1002041
1043677
504615
790738
1293703
1011591
371533
665313
803598
791133
897652
444485
627988
529645
958914
694693
703919
382989
690510
674762
288179
832375
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Table 5, cont.
~-glucuronidase

Acidic 386 and 389 Ion Areas and Heights (cont.)

P-Giu. Acidic
Sample No.

386
ion area

386
ion height

389
ion area

389
ion height

0026
0027
0028
0029
0030
0031
0032
0033
0034
0035
0036
0037
0038
0039
0040
0041
0042
0043
0044
0045
0046
0047
0048
0049
0050

2593
0
0
135
4419
2054
5957
82
31
0
4343
0
2158
0
0
0
1119
0
1307
213
1566
617
1208
249
2550

123824
0
0
8613
248727
106231
329455
5165
1833
0
243360
0
115533
0
0
0
67596
0
66627
11 243
40784
41287
70191
14048
70163

8176
13974
10196
8618
7339
8227
4858
3426
4072
6227
9778
7057
798 1
7694
9187
5977
10161
8794
3998
6636
9098
6164
10337
5381
6576

414499
756934
561887
473625
393727
435176
267655
192830
227105
345139
498037
404100
433329
424618
515476
329192
569095
488852
217594
343875
514134
348817
539342
254160
352187

Mean
Standard Dev.
Est. Std. Error

2807.72549
5126.102
517.788

127870.7647
220216.890
22244.130

10620.47059
4929.657
497.945

559227.1569
259735.274
26235.886

Table 5: Shows the areas and heights for the 386 and 389 ion fragments for the
acidic 13-glucuronidase extractions. Statistics were calculated for these values so
that they could be compared to the values obtained from use of 13-glucuronidase
at a basic pH.
Mean = LXIN
Sandard Dev. = .V[(LX2/N)-Mean2]

Est. Std. Error= SD/.V(N 1-1 + N 2-1 )

53

Table 6
P-glucuronidase Basic 386 and 389 Ion Areas and Heights

P-Giu. Basic
Sample No.

386
ion area

386
ion height

389
ion area

389
ion height

0001
0002
0003
0004
0005
0006
0007
0008
0009
0010
0011
0012
0013
0014
0015
0016
0017
0018
0019
0020
0021
0022
0023
0024
0025

1922
980
17091
576
216
456
446
0
122
4135
411
0
11192
124
0
16691
8624
979
1578
1222
1806
414
412
265
19845

110958
57389
879164
37884
14222
29245
28103
0
6674
227534
24930
0
564074
8121
0
919941
466782
25946
89029
69156
96186
24541
27367
13599
410506

8905
111 11
10983
10542
9005
9267
10388
11324
10237
7620
9664
10413
11776
9551
9079
9932
10216
11239
11368
11469
9074
10837
11 117
7961
14001

486048
598290
558492
594063
513497
481836
564070
610844
550501
402485
524213
547668
623748
540159
516598
505326
530720
617426
603157
612272
486637
575996
614232
423583
763267
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Table 6, cont.
P-glucuronidase Basic 386 and 389 Ion Areas and Heights (cont.)

P-Giu. Basic
Sample No.

386
ion area

386
ion height

389
ion area

389
ion height

0026
0027
0028
0029
0030
0031
0032
0033
0034
0035
0036
0037
0038
0039
0040
0041
0042
0043
0044
0045
0046
0047
0048
0049
0050

2275
0
0
153
4013
623
10448
250
64
0
2713
85
2316
0
0
0
969
14
2607
146
6708
968
778
140
8221

121766
0
0
9702
232969
38518
577149
15947
4271
0
156975
5762
127540
0
0
0
56657
850
138675
873 1
174948
57620
47532
7752
167351

10642
10640
10431
12378
20166
4208
11705
10501
10226
9833
8553
9962
11026
9991
8973
10646
12764
111 78
12394
12848
10300
10254
10177
10368
11146

543617
574128
594381
653794
1157706
226967
630015
555532
574329
531385
470859
538359
587095
562471
502693
593721
676718
621692
641159
671544
547208
542911
542692
539362
574344

119263.7647
210983.887
21311.504

10368.19608
2479.094
250.413

558827.4314
140068.840
14148.368

Mean 2615.372549
Standard Dev.
4716.679
Est. Std. Error
476.432

Table 6: Shows the areas and heights for the 386 and 389 ion fragments for the
basic J3-glucuronidase extractions. Statistics were calculated for these values so
that they could be compared to the values obtained from use of J3-glucuronidase at
an acidic pH.
Mean= :EX/N
Sandard Dev. = " [(:EX2/N)-Mean2]
Est. Std. Error = SD/"(N 1-1 + N2 -1)
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To determine if the two methods for extraction of L\-9-THC were significantly
different or not, at test was completed (See Table 7) using the 386 ion fragment data
from Table 5 and Table 6. First, the heights of the 386 ion from the acidic and basic
extractions were compared and at ratio calculated. This value was compared to a t table
for a .05 level of significance. The t ratio for the heights for the two extractions for the
386 ion was determined to not be significantly different. The value for the t ratio fell
well below the accepted value for a degree of freedom of 120.
The data from the areas for the 386 ion fragment for the basic and acidic
extractions was also statistically compared using a two tail t test. Again, at a .05 level of
significance for degrees of freedom of 120, the acidic and basic extractions proved to not
be significantly different. The t ratio for the two areas again. fell well below the t value
from the table.
Using three direct standards of L\-9- THC and its internal standard, a calibration
curve was made so that the concentrations from the 50 urine samples for the acidic and
the basic extractions could be determined. The L\-9-THC-D3 internal standard
concentration of the samples was 10 ng/mL and the L\-9- THC concentrations used were
2.5, 5.0, and 20.0 ng/mL. The curve was constructed using the 386 and 389 ion fragment
area ratios and was linear from 0 to 20 ng/mL as seen in Figure 3.
The concentration of L\-9- THC for each of the 50 samples for both extractions
was determined using this calibration curve. Concentrations of L\-9-THC for both the
acidic and basic extractions were determined so that they could be compared for
statistical difference also.
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Table 7
Statistical Comparison ofAcidic and Basic p-glucuronidase 386 Ion

Acidic 386 Height
Basic 386 Height

Mean

Standard
Error

130420.46
121641.32

22393.023
21458.045

Est Stand Error of
Difference

31014.43493
0.283

t (.05)( 100)=

Acidic 386 Area
Basic 386 Area

2856.16
2659.96

521.853
480.171

709.1507194

0.277

Table 7: Statistical comparison of the areas and heights of the 386 ion
fragment from the acid and basic ~-glucuronidase extractions. The extraction
methods following treatment with ~-glucuronidase are not significantly different.
Using the t value for a .05 level of significance for a degree of freedom of 120, the
calculated values proved not to be significantly different.
Est. Std. Error of Difference = --.f(SE 12 + SE22)
tratio

= (Mean,-Mean2)/SED
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. 16-lVIar-2010 + 08:22 :32
Compound 2 name: THC
Correlation coefficient: r = 0 .999860, r112 = 0.9997 19
Calibration cuNe : 0 .132712 *x +-0 .127612
Response type: Internal Std (Ref 1 ), Height* (IS Cone . I IS Height)
CuNe type: Linear, Origin: Exclude, Weighting: Null , Axis trans: None

2 .53

Response

-o.128 'h-'T"T"T"T'"T"'T'"''~..,..,...,..,."T"'T""T"'T"'T""T'"T"T'"T'""T'"T'"'T"'',~""T"T"T"T"T"T"T'
,'T"T'T"''...! ng/m 1
o.o

5 .o
Hi.o
15.o
Concentration (ng/ml )

20 .0

Figure 3. Calibration curve made from 3 standards of ~-9-THC at values of2.5,
5.0, and 20.0 ng/mL. It demonstrated the linearity of the standards as seen by the
r2 value.
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In order to further analyze the 13-glucuronidase acidic and basic extractions for
significant difference, the concentrations of Li-9- THC from each extraction were
statistically compared. The mean, standard deviation and standard error was calculated
for both sets of data. Through one of the two extractions, 36 of the 50 samples yielded a
concentration of Li-9-THC detectable by the GC/MS . 14 of the samples did not show to
contain any Li-9-THC or the concentration was below the limit of detection. These
samples that appeared to have 0 ng/mL Li-9-THC when extracted via acidic or basic
conditions were excluded from data analysis in order to not skew the statistical results.
The concentrations of Li-9-THC from both extractions can be found in Table 8.
Again, using the two-tail t test, at ratio was calculated (See Table 9) for the
difference in the concentrations of Li-9-THC extracted by both methods. The t ratio for
the concentrations from the acidic and basic extractions was found to fall below the
accepted value from the t table for a .05 level of significance at a degrees of freedom of
120. This calculation again proved that the two extractions were equally efficient in
extracting Li-9- THC and were not statistically different.
After determining that the 13-glucuronidase acidic and basic extractions were not
significantly different, the percent recovery for the two extractions was calculated. This
was completed by using the average area and height of the 389 ion fragment because it,
unlike the 386 ion fragment from Li-9-THC, was added to each ofthe standards and
samples in the same concentration. Using the 5.0 ng/mL standard ' s 389 ion's height and
area as the theoretical recovery, the average percent recovery for each extraction was
calculated using the average area and height from both extraction techniques. Table 10
shows the average percent recovery for the 389 ion fragment based off of area and height.
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The percent recoveries for the two extractions were very close in value, but the acidic
extraction did show a slightly better recovery than the basic extraction.
Another goal ofthis research was to compare the 6 -9-THC concentrations found
in the urine samples from donors to the time frame since each person had last smoked to
determine a peak 6-9-THC concentration versus time in an uncontrolled study. The time
elapsed since the participant had last ingested marijuana versus the concentration of 6 -9THC found in their urine by both extractions was plotted so that a relationship could be
easily seen. As compared to literature, the peak concentration of 6-9-THC in urine from
the participants occurred approximately 1 hour earlier than it did in controlled studies
(See Fig. 4).
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Table 8
p-glucuronidase Acidic and Basic Concentrations

Sample No.

0001
0002
0003
0004
0005
0006
0007
0009
0010
00 11
0012
0013
00 14
0016
0017
0019
0020
0021

p-glu. Acid Concentration P-glu. Base Concentration

2.92
1.99
12.25
0
1.28
1.45
1.39
1. 12
4.72
1.46
1. 13
8.62
0
13.45
8.1
2.15
1.86
2.92

2.68
1.68
12.85
1.44
1. 17
1.42
1.34
1.05
5.22
1.32
0
7.78
1.07
14.68
7.6
2.07
1.81
2.45
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Table 8 (cont.)
f3-glucuronidase Acidic and Basic Concentrations (cont.)

0022
0023
0026
0029
0030
0031
0032
0033
0034
0036
0037
0038
0042
0044
0045
0047
0048
0050

1.43
1.36
3.2
1.11
5.72
2.8
10.24
0
0
4.64
0
2.97
1.86
3.25
0
1.85
0
2.51

1.28
1.3
2.65
1.07
2.48
2.24
7.86
1.18
1.02
3.47
1.05
2.6
1.59
2.59
1.06
1.76
1.62
0

Mean
Standard Deviation
Standard Error

3.08
3.43
0.42

2.94
3.30
0.40

Table 8: Concentrations of ~-9-THC found using both the basic and acidic
~-glucuronidase methods. The omitted samples are ones that did not show
to contain ~-9-THC when extracted using either method.
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Table 9

Statistical Comparison ofConcentrations

p-glu Acid
Cone.
P-glu Basic
Cone.

Mean

Standard
Error

3.08

0.42

2.94

0.40

Est Stand Error of
Difference

0.58

0.241

Table 9: Statistical comparison of concentrations from the acidic and basic
13-glucuronidase extractions. The t ratio for these concentrations fell below
the t value for .05 level of significance for a degre of freedom of 120 and
showed no significant difference.
Est. Std. Error of Difference= --.f(SE 2 + SEl )
1

lratio

= (Mean,-Mean2)/SED
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Table 10
Percent Recovery

Standard
Height
Area

Acidic Extraction
Height
Area

Basic Extraction
Height
Area

590401

570403

10825

569996

10567

96.61%

103%

96.50%

100%

10555

Average % Recovery

Table 10: Summary of percent recovery of the ~-9-THC-D3 389 ion fragment. It
shows that the acidic and basic pH extractions both prove to be effective in
extracting ~-9- THC-D3 internal standard from urine.
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Concentration vs Time
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Figure 4. Plot of concentration of ~-9- THC in urine versus time elapsed after an
individual smoked. Peak THC concentration showed to be between 30 minutes and
1.5 hours after smoking.
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CHAPTER V
DISCUSSION

While marijuana contains many different cannabinoids, one in particular, 6 -9Tetrahydrocannabinol (6-9-THC), is responsible for the psychoactive effect experienced
by users of marijuana. 6 -9-THC only becomes psychoactive after the compound is
heated. The effects experienced by users of marijuana are not consistent person to person
and therefore make the drug hard to classify. Some of the more common effects of
marijuana are described as euphoria, impaired memory, and increased appetite and heart
rate (Huestis, 2006).
At high doses, marijuana is a central nervous system depressant. Marijuana is
usually smoked due to the quick and effective delivery ofthe 6 -9-THC to the brain, but it
can also be orally ingested after heated. The drug acts upon a user through cannabinoid
receptors found in the brain. When smoked, 6 -9-THC has a higher bioavailability than
when it is ingested orally. Effects can be felt almost immediately by a user when the
marijuana is smoked, but when orally ingested the drug takes longer to take effect.
However, once the drug does take effect after being orally ingested, the effects last longer
(Huestis, 2006).
Due to its lipophillic nature, 6 -9-THC is readily metabolized by P450 enzymes in
the body to its two major metabolites, 11-0H-THC and THC-COOH. 11-0H-THC is
psychoactive while THC-COOH is not (Kemp, 1995). THC-COOH is the end product
for the metabolism of 6-9-THC. The THC-COOH is slowly cleared from the blood into
the urine because it is polar. THC-COOH also has a long half life in the body because it
is stored in the fat and is not readily cleared from the body because it is also lipophillic.

66
The lipophillic nature of ~-9-THC and THC-COOH causes the majority of each
compound to be conjugated to glucuronic acid in order to make it more water soluble
before it enters the urine to be excreted from the body. This means that when the

~-9-

THC or THC-COOH is found in urine, it is attached to glucuronic acid. This glucuronide
bond must be broken in order for the compounds to be extracted and detected via
chromatographic methods.
While THC-COOH can be found in a person's urine hours or days after marijuana
ingestion, it is not psychoactive and indicates nothing about the impairment of the
individual. When trying to determine impairment from marijuana use, the compound that
is looked for in a person's urine is the parent drug, ~-9-THC. Since it is known that

~-9-

THC is readily metabolized once it enters the body, its pre~ence in urine is indicative of
recent marijuana use. A high concentration of ~-9-THC in urine would indicate that the
person used marijuana recently and is under the influence of the drug.
With marijuana use becoming more common, quicker, efficient methods for
determining

~-9-THC

concentration and studies relating it to impairment are necessary.

In this research, urine samples were collected from a variety of known users of marijuana
at different times after the person ingested marijuana using various devices. The samples
were treated with either an enzyme or strong base to break the glucuronide bond. Three
different extraction methods were used and the results from each compared in order to
determine efficiency of the extraction method.
The first experiment was conducted in order to test the efficiency ofNaOH and~
glucuronidase for cleaving the bond between the glucuronic acid and the

~-9- THC,

and

to determine if the extraction could be completed at an acidic pH and still be efficient.
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The f3-glucuronidase method was completed at an acidic pH while the NaOH extraction
was performed at an alkaline pH. When f3-glucuronidase was used to break the bond, and
the extraction completed at an acidic pH, ~-9- THC was recovered in 39 of the 50 urine
samples and could be quantitated in 29 of the samples. This method proved to be
efficient for extracting ~-9- THC from the urine samples. When NaOH was used to break
the glucuronide bond and to create an alkaline pH for the extraction,

~-9-THC

was not

recovered in any of the same samples. This showed that the strong solution ofNaOH did
not work as well, if at all, as the f3-glucuronidase in cleaving the glucuronide bond from
~-9- THC

before extraction.

With no

~-9- THC

to use for the comparison of pH environments for the

extraction, these two extractions were compared using the internal standard, ~-9-THCD3.

~-9-THC-D3

could be used because it was not conjugated in the urine and therefore

did not have to be freed by use of the NaOH or f3-glucuronidase. The deuterated internal
standard was added to each of the samples prior to the extraction process in equal
concentrations so that the

~-9- THC

could be quantitated. When the area and height of

the base ion for the internal standard was compared for the acidic and alkaline
extractions, the alkaline extraction using NaOH was shown to be more efficient. The
basic extraction had a larger mean for both area and height; it had smaller standard
deviations than the acidic extraction, and lower estimated standard errors for the area and
height. For the extraction of the internal standard, the basic extraction using the NaOH
proved to be the best option, even though it was completely inefficient for the recovery of
~-9-THC.
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When data from both extractions were statistically compared using a two-tail t
test, the two extractions of L1-9-THC-D3 proved to be significantly different. The
calculated t ratios for the test should have fallen below 1.98 for 120 degrees of freedom
for a .05 level of significance in order for the two procedures to be considered statistically
not different. For the comparison of the data from the areas ofthe acidic and basic
extraction, t (.0 5) c1oo) = 2.153, and for the heights, t (0.5) ( 100) = 17.357. These t ratios
showed that the two procedures were significantly different and that the basic extraction
was more efficient in the extraction of the internal standard.
Because of the absence of Li-9-THC in the first experiment, the only data obtained
concerned the internal standard. In order to completely determine if an acidic extraction
was as efficient as an alkaline extraction, Li-9- THC would need to be recovered in each.
It was decided that the best way to complete this was to treat all samples to be compared

with 13-glucuronidase to first cleave the glucuronide bond. Another set of samples were
then treated with 13-glucuronidase, identical to the acidic process, but were made alkaline
using NaOH prior to extraction.
These samples were analyzed and Li-9- THC recovered from them. The basic
extraction using 13-glucuronidase showed recovery in 41 of the 50 urine samples and the
Li-9-THC was quantitated in 34 ofthe samples. Now that two different pH extractions
yielded recovery of Li-9-THC, the effect of pH on extraction efficiency could be
determined. While the statistical data for the two extractions were close in value, the
mean for the area and height of the acidic extraction was higher than the basic. However,
the standard deviations for the basic extraction were lower than the acidic, and the
estimated standard error for the basic extraction was lower than the acidic extraction.
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After the initial calculations for both the area and the height for the basic and acid
extractions were done, a two-tailed t test was performed for the area and height of the
base ion for

~-9-THC.

A t ratio for the area and height for the two methods was

calculated and compared to the t value of 1.980 from the table for a .05 level of
significance for 120 degrees of freedom. For the area, t
height, t

(.o 5) ( IOO)

(.05) ( IOO)

= 0.277 and for the

= 0.283. Both of these values fall well below the accepted value of

1.980 and were determined to not be significantly different. This showed that whether
the extraction was completed at an acidic or alkaline pH, it was still efficient for the
extraction of ~-9-THC from urine.
A calibration curve was made using direct standards in order to determine the
actual concentration of ~-9-THC recovered by each method. Once these concentrations
were determined, they too were analyzed for statistical difference. For the acidic
extraction, 29 of the urine samples were able to be quantitated and using the basic
extraction process, 34 of the samples were able to be quantitated. The mean
concentration for the acidic extraction (3.08 ng/mL), however, was higher than the mean
concentration (2.94 ng/mL) from the basic extraction even though 5 fewer samples were
able to be quantitated. The standard deviation and standard error for the acidic
extractions were slightly higher than the basic extraction' s standard deviation and
standard error. For the acidic extraction, the standard deviation was 3.43 and for the
basic, 3.30. Standard error for the acidic and basic extractions was 0.42 and 0.40,
respectively.
Using the above data a two-tail t test was performed for a 0.5 level of significance
for 120 degrees of freedom. At ratio was determined and compared to the 1.980 value.
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I(.OS) ( IOO)

= 0.241 fell below the acceptable limit and the two extractions were again

proven to not be significantly different. Since no significant difference between the two
methods was found using the area or height of the base 8.-9-THC ion fragment or by
using the concentrations found when using each extraction, the methods are considered to
both be efficient when extracting 8.-9-THC from urine.
The average percent recovery of both of the procedures was calculated in addition
to the statistical comparisons. Using the average area and average height of the 8.-9THC-D3 recovered for both the acidic and basic extractions, percent recovery was
calculated. The internal standard was used to determine percent recovery because the
same concentration was added to all of the samples and to the standards. The 8.-9-THC
would have not produced as accurate of results because tl;le concentrations varied from
sample to sample and would require finding a sample with the exact concentration as one
of the standards. Using the internal standard recovery from a standard that was directly
injected as the theoretical recovery, the average percent recovery from the acidic and
basic extractions could be determined. The average of the areas and heights from each
method was used because ofthe wide range of value between the lowest and highest
recoveries from the samples. A percent recovery of 96.61 % and 103 % was determined
for the height and area of the acidic extraction. For the basic extraction, a percent
recovery of96.50% and 100% was calculated for the height and area, respectively. The
acidic extraction yielded more than 100 % for the recovery of the area; this can be
attributed to the slight change in the instrument's response at different times. The acidic
extraction showed a slightly higher percent yield than the basic extraction, but overall the
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two both had high percent yields and again both proved to be efficient in the extraction of
L1-9-THC from urine.
This research compared the efficiency of two methods of breaking the
glucuronide bond as well as the efficiency of completing the extraction at an acidic pH.
According to the literature (Kemp, et al., 1995), 13-glucuronidase from the E. coli bacteria
works best when hydrolyzing the glucuronide bond from L1-9-THC. The research
conducted here completely agreed with the literature regarding the best option for
cleaving the bond. Using the NaOH was not just less efficient than the 13-glucuronidase;
it yielded no results at all for the extraction of L1-9-THC from the urine samples.
While the findings of this research are consistent with the literature concerning
the best process for freeing L1-9-THC, the time used for the. enzymatic process in this
research is much less than that ofthe literature. Kemp et al. (1995) reported allowing the
samples to incubate overnight while this procedure allowed the urine samples to incubate
for just 1.5 hours at the same temperature as from the literature. The less time used for
incubation greatly reduces the time for the extraction process and makes this a desirable
technique for laboratories with a high volume of samples.
Literature describes the extraction of L1-9-THC at an alkaline pH only (Kemp et
al., 1995; Huestis, 2006). An acidic extraction of the compound has not yet been used.
L1-9-THC is not an acidic compound. It has a pKa of 10.6 (Clarke 's Isolation and

Identification of Drugs, 1986) which means that it should be extracted best at an alkaline
pH. To extract the L1-9-THC at an alkaline pH after the use of the 13-glucuronidase would
mean having to add a strong basic solution to each sample. This creates an extra step in
the extraction process which means more time and more consumables used.
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Since the extraction is equally efficient when performed at an acidic pH as an
alkaline pH as shown through this research, the omission of this step would save time
during the extraction as well as the time spent making the solution initially. The
omission of this step would also mean that less alkaline salt would be used. Since only a
small amount of the basic solution can be used to increase the pH of the urine to an
alkaline environment, the solution used must be highly concentrated. This means a large
amount of the salt is used. Not performing this step would mean saving money on
chemicals, saving time spent making the solution as well as saving an extra step during
the extraction process all while still obtaining correct results.
Research similar to this study (Manno et al. , 200 1; Huestis et al., Blood
Cannabinoids I, 1992) has been conducted in controlled .situations where the marijuana
users are brought into a laboratory setting and allowed to smoke marijuana cigarettes
according to a computerized procedure. In these studies, the percent of ~-9-THC in each
marijuana cigarette was known by the researchers and the smoking process computerized.
For the smoking process, the participant is prompted when to inhale, how long to hold the
smoke, when to exhale, and how long to wait until the next inhalation by a computer.
The process is very standardized in order to establish consistency for these controlled
studies.
In a real-life setting, users do not smoke marijuana according to a protocol;
inhalation, exhalation, and the occurrence of the next inhale are all at random and
dependent on the user. The percent of ~-9- THC in the marijuana is also not known.
Since the samples used during this research were all from marijuana users who smoked
by their own means, the peak concentration of ~-9-THC found in the urine was shifted to
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an earlier time than literature reported. Controlled studies such as the ones performed by
Manno et al. (200 1) and Huestis et al. (Blood Cannabinoids I, 1992), reported the peak /J.9-THC concentration in urine to be around 2 hours after smoking ceased. The research
here showed the highest concentrations occurring between 30 minutes and 1.5 hours with
the peak concentration time to be around 1 hour. This difference can be attributed to the
smoking procedures for controlled studies versus real-life smoking procedures. An
unknown percent of /J.-9-THC in the marijuana used as well as how the user smoked
could very well account for the earlier peak concentration of /J.-9-THC in the urine
samples.
Another possible explanation for the quicker peak concentration time is the
activity of the user while smoking. If the person who ingested marijuana is in a
laboratory they will not be as active as a user who used marijuana in a social situation.
Moving around may increase excretion of the drug and will therefore cause it to enter the
urine more rapidly. More research will need to be conducted to further explain the earlier
peak concentration found when using samples from smokers not under a controlled study.
Also, when marijuana users in real-life situations ingest marijuana, it is in combination
with ethanol. Ethanol is a natural diuretic and could possibly cause the /J.-9-THC to be
excreted quicker by these users.
This research focused on three different questions concerning the extraction of /J.9-THC from urine: which treatment, either NaOH or r3-glucuronidase, would best
hydrolyze the glucuronide bond, could the extraction be completed at an acidic pH and
still yield the expected concentrations of /J.-9-THC, and finally, does peak concentrations
from smokers in uncontrolled studies agree with that reported by literature? This
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research proves to be consistent with the literature when determining the best method for
breaking the glucuronide bond; it shows that a step of the extraction process can be
omitted and not effect the yield of ~-9- THC, and it offers insight to the time versus urine
concentration of real-life marijuana users.
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APPENDIXB
RESEARCH PROTOCOL
I. Project Goals:
-To analyze urine samples from individuals who use marijuana for the presence of
~-9- Tetrahydrocannabinol. Variations in the habits of the donors, such as how often the
donors smoke and the time period since they last smoked, will be compared to the
concentration of ~-9- Tetrahydrocannabinol during the analytical process.

II. Protocols
Samples to be collected
The principal investigator's laboratory will not be involved in the collection of any of the
human samples.
111

Urine samples will be obtained from a minimum of 50 anonymous, volunteer
donors who are at least 21 years of age. Any sample suspected of being donated
by a volunteer under 21 years old will be discarded immediately.

•

Each participant will receive a plastic urine specimen cup in which his/her sample
will be collected. This participant will receive the urine specimen cup in a brown
paper bag from a third party individual so that he or she remains anonymous to
the principle investigator. The third party will be expressly instructed not to give a
collection kit to anyone under 21 years of age.

•

The individual receiving the collection kit from the third party may give the kit to
another volunteer donor, provided they were informed by the third party that no
one under the age of 21 shall participate in this study.

111

The collection of the urine by the volunteer donor will be completed in a private
place chosen by the donor. The overall procedure will take approximately 10
minutes to complete.

•

The donor will provide the following information on a provided strip of paper:
heavy smoker (6-7 days per week), medium smoker (3-5 days per week), light
smoker (1- 2 days per week), or recreationally (1-3 times per month.)

•

In addition to the number of times a subject smokes per week or month, the time
period between when he/she last smoked and the time of collection will also be
recorded by the participant on the data form.
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11

The manner in which the participant smoked marijuana will be recorded on the
data form provided.

11

No other identifying information will be collected on the urine specimens
donated. This project is for research purposes only and any findings will not be
used against the participants under any circumstances.

11

As samples are received, they will be numbered and categorized by the committee
chair so that the category of the sample remains unknown to the principle
investigator so as not to bias the principle investigator during any of the analytical
process. (See categories stated above.)

11

Urine samples will be kept in a locked freezer in a locked, limited access
laboratory for six months following project completion and then discarded in a
manner that meets biohazard and safety regulations.

Subject Population
11

Ill

Subject population is not a variable within the study and therefore sample
donations will be accepted from donors of both genders and all ethnic
backgrounds.
Control samples will also be collected from 2 individuals known not to have
ingested marijuana by any method within the past year

Procedure and Research Locations
11

Samples will be placed in a plain paper bag and dropped off by participants into
an unmarked box located at Arthell Kelley Hall.

11

Analysis of these samples will take place at The University of Southern
Mississippi, School of Criminal Justice, Arthell Kelley Hall research laboratory.

III. Benefits
111

There are no benefits for individuals participating in this research project.

IV. Risk
Sampling Risk
II

There are no risks involved during the collection of the samples by the volunteers.
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Ill

Volunteers will be released from the study as soon as the urine sample is collected
or delivered.

l.tl

Final data and chromatograms will be maintained in a locked desk in the
committee chair's office for a period of 6 months. Data will be shredded at the
end of the 6 months and then discarded.

Confidentially and Anonymity
Ill

No identifying information will be collected during the sample collection process.

l.tl

Samples will be stored in a secure area at Arthell Kelley Hall. They will be
placed in a locked freezer located in a locked, limited access laboratory. Only the
principle investigator and committee chair have access to the laboratory.

V. Informed Consent
l.tl

Each participant will receive a letter along with the urine specimen cup that
explains what he or she should and should not place on the specimen cup as well
as where and how to bring the sample. (A copy of this letter is enclosed.) No
signature, participant number, or any other identifying information will be
required for the volunteer to divulge due to the anonymity of the project.
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APPENDIX C
INFORMED CONSENT
Participation in this research project is completely voluntary and donors may
withdraw at any time without penalty or prejudice and no personal information shall be
disclosed by the principle investigator of the project. The procedure will take
approximately 10 minutes for the volunteer to void his or her bladder and to fill out the
form.
Samples collected will be used for the analysis of L1-9- THC following extraction
of the urine samples. All urine samples will be stored in a locked freezer in a locked
laboratory. The data obtained from the samples will be kept in the committee chair's
office in a locked cabinet during the project. Both the urine samples and the data will be
discarded 6 months after the project is complete.
•

Urine specimen cups, brown paper bags, tamper-prooftape, and the data form are
provided for the collection of the sample.
• After collecting the urine sample in the provided urine specimen cup, the
participant should place one of the following labels on the provided data form to
indicate the number of times per week that he/she smokes marijuana: heavy (6-7
days), medium (3-5 days), light (1-2 days), or recr:eationally (1-3 times a month).
• The time that has elapsed since the donor last smoked should also be placed on
the data form along with information concerning the manner in which the
participant smoked marijuana (i.e. pipe, bong, blunt, etc.).
111 The participant should NOT write his/her name, initials, or any other identifying
information on the data form.
• Once these indications have been marked on the data form, it and the urine
collection cup should be placed in the brown paper bag provided and the bag
sealed with tamper-proof evidence tape. NO markings should be placed on this
bag.
• After these steps have been taken, donors should either bring his/her sample or
have someone else deliver his/her sample to Arthell Kelley Hall at The University
of Southern Mississippi. The donor' s brown paper bag containing the urine
sample will be placed in an unmarked brown box in the front lobby next to the
receptionist's desk.
Questions concerning the research, at any time during or after the project,
should be directed to Ashlyn Harmon at 225.937.7952 or 601.266.5212. This project
and this consent form have been reviewed by the Human Subjects Protection
Review Committee, which ensures that research projects involving human subjects
follow federal regulations. Any questions or concerns about rights as a research
participant should be directed to the Chair of the Institutional Review Board, The
University of Southern Mississippi, 118 College Drive #5147, Hattiesburg, MS
39406-0001, (601) 266-6820.
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0

Please indicate the number of times you smoke marijuana in the following blank.

0

How many hours has it been since you last smoked marijuana? _ _ _ __

0

Were you smoking marijuana at the time of urine collection? _ _ _ __

0

Which manner or apparatus did you use to smoke marijuana? _ _ _ __

***DO NOT PLACE ANY IDENTIFYING INFORMATION ON THE
SPECIMEN CUP,
PAPER BAG OR THIS PAPER.
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